Demonstrate Clinical Utility. Impact Patient Care.

Critically evaluate the latest CTC technologies fuelling this field and witness first hand case studies demonstrating clinical utility and impacting patient care.

This November circulating cancer biomarker leaders across the globe will convene to share unpublished findings at World CTC Boston providing you with the inside track to the latest developments in the lab and clinic.

With over 150+ CTC experts including; drug developers, technology providers, academics, clinicians and regulators successfully tackling the latest scientific challenges at the forefront of CTC research.

  • Be the first to discover unpublished results from cutting edge CTC culturing research
  • Gain the latest insights on advanced molecular characterization techniques
  • Understand the dynamic process of EMT and the impact for your CTC research going forward
  • Learn best practises for developing Chemosensitivity assays
  • Get access to the latest clinical results months before they are released

The number of CTC capture technologies entering this rapidly evolving field is increasing. Critical data is being uncovered about the nature of CTCs and their complex role in metastatic cancer. This is facilitating ground breaking advances in culture and in vivo modelling of CTCs.

At World CTC Boston 50+ experts speakers will unveil the latest insights to dramatically improve your approaches to CTC research.  To achieve your goal of demonstrating clinical benefit in patients this comprehensive program covers a breadth and depth of topics that means no matter what your challenge, there’s an answer for you at this year’s meeting.

Moving beyond CTC….

This year World CTC will embrace the huge potential of other circulating cancer biomarkers currently paving the way toward advanced non invasive testing.

With the biomarker community realising the enormous clinical value locked away in cell-free DNA, Exosomes, MRNA and miRNA World CTC has introduced a dedicated track featuring  an entire 2 days worth of content just focussing on their potential in both the clinic and drug development. For more info on this conference stream please visit the Circulating Biomarker Research Page (link to separate page with info?)

Tailor your World CTC Experience…

Day 1

Plenary Sessions: Latest Insights on Capture, Enumeration & Characterization

Track 1: Advanced CTC Application

Track 2: Understanding the Science Behind CTC

Track 3: Circulating Biomarker Research

Clinical Applications of CTC to Improve Prognosis & Treatment Choices


 Latest Research: Culturing CTCs and Advanced in vivo techniques
 Exploring the Potential of cfDNA in the Clinic

Latest Clinical Data: First Hand Clinical Studies

The Role of EMT in Metastasis & the Heterogeneous Population


 Utilising cfDNA in Drug Development

Plenary Sessions: Understanding Regulation and Reimbursement for Circulating Cancer Biomarkers
 

Day 2

Plenary Sessions: Latest Insights on Capture, Enumeration & Characterization

Track 1: Advanced CTC Application

Track 2: Understanding the Science Behind CTC

Track 3: Circulating Biomarker Research

Practical Applications in Drug Development & Clinical Trials

 

Increasing Our Understanding of Cancer Biology Using Molecular Characterization


 Exploring Exosomes as a Cancer Biomarker

Working with Pathologists to Maximise use of CTC Testing

 

Best Practices for Developing Chemosensitivity Assays

The Evolving Role of mRNA and miRNA in Cancer Biomarker Research

Plenary Sessions: Understanding the Regulatory Environment and Achieving Reimbursement

Download the draft agenda now to:

  • Read through the provisional agenda and content streams
  • Understand the array of benefits you will get from attending World CTC
  • Explore the Sponsorship opportunities still available
  • Identify the sessions you want to attend

Download Draft Agenda | Prices & Packages | Register Now